News and Updates

Latest News

Stay informed with the latest updates from Saiiv Monitoring Solutions. From research breakthroughs to clinical trials and investor milestones, explore how we’re driving innovation in health monitoring and chronic disease management.

Most Recent

Emergence Investment Conference

February 26-27

Come and meet the team, ask questions about our products and watch us showcase our product presentation.

We’ll be explaining in detail why the gaps in the medical device market and how our monitoring solutions overcome these gaps at an affordable and scalable level.

Grant Success Stories

Saiiv has been awarded multiple grants to advance our technology:
NSSN Grand Challenge: Supporting innovative sensor solutions for heart failure monitoring.
NSW MVP Ventures: Driving early-stage development and product realization.
European Union – NextGeneration – EU National Recovery and Resilience Plan (200 patients) – Mission M6 – Component C2 – Investment 2.1 Enhancement and strengthening of biomedical research of the SSN : “New multimodal CArdioREspiratory MOnitoring DEvice to improve chronic patient management (CARE-MODE)” (project ID: PNRR-POC-2022-1237683)

Clinical Trial Announcements

We’re actively conducting and planning clinical trials to validate our solutions. Stay updated on trial recruitment and findings:
Current Trials: No trials currently open for participant enrolment in Australia. We have a 200 patient trial underway in Italy to gether more data for Saiiv PulsePoint sensor technology compared to echo.
Upcoming Trials: New studies launching in 2025 include a pilot study of the Saiiv PulsePoint Minimal Viable Product at a Sydney hospital.
Completed Trials: 50 patient trial of Saiiv PulsePoint sensor technology in heart failure patients at The Alfred in Melbourne and St Vincents in Sydney.

Intellectual Property and Publications

We have 2 licensed patents from Western Sydney University for Saiiv Lifeband that have been granted in multiple countries
We have 3 patents for Saiiv PulsePoint all at National Phase in multiple jurisdictions. The first one on the sensor design was granted in January 2025 in the US and China.

Events and Conferences

Catch us at upcoming events and conferences:
Emergence Sydney 2025: Premier investment conference on February 27, 2025. Event details.
Future presentations, exhibits, and publications will be announced here.